The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 UK Patient Groups

The ‘Corporate Reputation of Pharma’ survey - the 2021 UK edition is now in its 10th year, and two years into the Covid-19 pandemic. Between November 2021-February 2022, the survey collected the opinions of 111 UK-based patient groups on the performance of the pharmaceutical industry during 2021.

Patient groups responding to the ‘Corporate Reputation of Pharma’ survey are uniquely positioned to comment on the pharma industry’s performance during the pandemic. Patient groups not only understand the perceptions of patients but are also the only healthcare stakeholder to network with all other stakeholders in the healthcare system.

The report provides details on: 

• How the analyst measures pharma’s corporate reputation from a patient perspective; 
• The headline results of the 2021 UK element of the ‘Corporate Reputation’ survey; 
• The companies included in the 2021 UK analysis; and 
• The profiles of 2021’s respondent UK patient groups. 

Companies assessed for corporate reputation in the 2021 UK report 

AbbVie - Amgen - AstraZeneca - Bayer - Biogen - Boehringer Ingelheim - Bristol Myers Squibb - Eli Lilly - Gilead Sciences - GSK - Janssen - Merck KGaA - MSD - Novartis - Pfizer - Roche - Sandoz - Sanofi - Takeda - Teva - UCB 

COMPANY RANKINGS IN THE UK IN 2021 

• The top-three pharma companies in the UK in 2021, out of 21 companies, ranked for their overall corporate reputation (as assessed by respondent UK patient groups familiar with the company): Pfizer, 1st - Roche, 2nd - AstraZeneca, 3rd. 
• The top-three pharma companies in the UK in 2021, out of 9 companies, ranked for their overall corporate reputation (as assessed by respondent UK patient groups working with the company): Pfizer, 1st - AstraZeneca, 2nd - Janssen, 3rd.
• The top-three ‘big-pharma’ companies in the UK in 2021, out of 13 ‘big-pharma’ companies, ranked for their overall corporate reputation (as assessed by respondent UK patient groups familiar with the company): Pfizer, 1st - Roche, 2nd - AstraZeneca, 3rd. 

Who Should Read this Report? 

Customer Types (Organisations)

• Pharma companies
• Biopharma companies
  • Regulatory authorities (e.g EMA, FDA) 
  • NGOs and health charities (usually FOC) including Patient Groups
  • Research and academia

Job Titles/Functions for Pharma and Biopharma Organisations

Core: 

• Patient Relations
• Corporate Reputation
• Public Affairs
• Professional Affairs
• Patient Advocacy
• Communications
• Market Research

Secondary: 

• R&D
• Health economics
• Outcomes Research
• Medical Affairs
• Marketing
• Brand teams
• Market Access 
• Regulatory